[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Merus N.V. Common Shares (MRUS)
Merus N.V. shares hit a 1-year high of $XXXXX due to positive clinical trial results and analyst upgrades. Social media engagement is up, with many users discussing the stock and its potential.
About Merus N.V. Common Shares
Merus N.V. Common Shares (MRUS) is a biopharmaceutical company developing cancer therapeutics.
Merus N.V. Common Shares uses the ticker $MRUS for trading. Listed in the Stocks and category within the Healthcare sectors.
Insights #
- Merus N.V. Common Shares (MRUS) trading volume is up XXXXXX% from the previous week.
- Merus N.V. Common Shares (MRUS) market cap is up XXXXX% from the previous X months.
- Merus N.V. Common Shares (MRUS) social dominance is up XXXXX% from the previous week.
- Merus N.V. Common Shares (MRUS) galaxy score™ is up XX% from the previous month.
- Merus N.V. Common Shares Price hit a high of XX for the hour
- Merus N.V. Common Shares Price hit an all time of XX for the hour
Price: $XXXXX #
Price 24-Hour Chart Data
The XXXXX% price surge in MRUS is driven by positive clinical trial results, analyst upgrades, and high social media engagement. The stock price is currently at $63.30, hitting a 1-year high, and the positive news indicates a likely continuation of the upward trend.
| 24-Hour | 7-Day | 30-Day |
|---|---|---|
| XXXX% | XXXXX% | XXXXX% |
1-Year High: $XXXXX on 2025-07-19
1-Year Low: $XXXXX on 2025-04-08
AltRank: XXX #
AltRank 24-Hour Chart Data
Merus N.V. Common Shares (MRUS) is currently AltRank #717 based on combined combined social and market metrics
Daily Average: XXX
1 Week: XXX +29
1 Month: XXX +410
6 Months: XXX -XXX
1 Year: XXX -XXX
1-Year High: XXXXX on 2025-05-13
1-Year Low: XX on 2025-05-25
Galaxy Score: XXXXX #
Galaxy Score 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX +11
1 Month: XX +15
6 Months: XX -X
1 Year: XX +1
1-Year High: XX on 2024-09-30
1-Year Low: XX on 2024-09-07
Engagements: XXXXX #
Engagements 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XXXXX
1 Week: XXXXXX -XX%
1 Month: XXXXXXX -XX%
6 Months: XXXXXXXXX +75%
1 Year: XXXXXXXXX -XX%
1-Year High: XXXXXXX on 2025-07-10
1-Year Low: XX on 2024-09-07
| Social Network | X |
|---|---|
| Engagements | XXXXX |
Mentions: XX #
Mentions 24-Hour Chart Data
Current Value: XX
Daily Average: XX
1 Week: XXX -XX%
1 Month: XXXXX +37%
6 Months: XXXXX +305%
1 Year: XXXXX +504%
1-Year High: XXXXX on 2025-07-10
1-Year Low: X on 2024-09-29
| Social Network | X |
|---|---|
| Mentions | XXX |
Creators: XX #
Creators 24-Hour Chart Data
XX unique social accounts have posts mentioning Merus N.V. Common Shares (MRUS) in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
1 Week: XXX -XX%
1 Month: XXXXX -XX%
6 Months: XXXXX +473%
1 Year: XXXXX +777%
1-Year High: XXX on 2025-05-25
1-Year Low: X on 2024-09-29
The most influential creators that mention Merus N.V. Common Shares in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @SteveDJacobs | X | XXXXX | X | XXXXX |
Sentiment: XX% #
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -XX%
1 Month: XX% -XX%
6 Months: XX% +12%
1 Year: XX% -XX%
1-Year High: XXX% on 2024-07-26
1-Year Low: X% on 2024-11-17
Most Supportive Themes
- Positive Clinical Trial Data: (60%) Positive clinical trial results of Merus's drug, petosemtamab, particularly its high response and survival rates in head and neck cancer patients.
- Analyst Price Target Increases: (20%) Several social media posts highlight analysts raising price targets for MRUS based on the promising clinical trial data.
- Recommendation by Social User: (5%) Many social media users are sharing or following a user called @marohaalhob1.
Most Critical Themes
- Trial Data Comparison Concerns: (1%) Some users are expressing concerns over comparing trial results with different patient populations and treatment contexts.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXXXX | XX% | XXXXX | XX% | XXX | X% |
| Total | XXXXX | XX% | XXXXX | XX% | XXX | X% |
Social Dominance: XXXXX% #
Social Dominance 24-Hour Chart Data
Current Value: XXXXX%
Daily Average: XXXXX%
1 Week: XXXXX% +0.00613%
1 Month: XXXXX% -XXXXX%
6 Months: XXXXX% -XXXXX%
1 Year: XXXXX% -XXXXXXXXXXXXXXXXXXXXX%
1-Year High: XXXXX% on 2025-05-25
1-Year Low: XXXXXX% on 2024-09-29
Market Dominance: XXXXXXX% #
Market Dominance 24-Hour Chart Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-03-31
1-Year Low: XXXXXXX% on 2025-05-15
Market Cap: $XXXXXXXXXXXXX #
Market Cap 24-Hour Chart Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXX +$15%
1 Month: $XXXXXXXXXXXXX +$19%
6 Months: $XXXXXXXXXXXXX +$67%
1 Year: $XXXXXXXXXXXXX +$25%
1-Year High: $XXXXXXXXXXXXX on 2025-07-18
1-Year Low: $XXXXXXXXXXXXX on 2025-04-08
Top assets mentioned In the posts about Merus N.V. Common Shares in the last XX hours
Strategy (MSTR) Strategy (MSTR) Rainmaker Games (RAIN) Akropolis (AKRO) Tesla, Inc. (TSLA) Arcblock (ABT) Taiwan Semiconductor (TSM) Alpine Immune Sciences, Inc. Common Stock (ALPN) Advanced Micro Devices (AMD)
Top topics mentioned In the posts about Merus N.V. Common Shares in the last XX hours
pltr, $kidz, $brk, $bntx, mstr, $cdio, $btai, $mstr, strategy, stocks financial services, nvda, soun, qbts, pep, rklb, gme, apld, spy, $mlgo, $rain, $argx, $cdtx, telo, nio, hood, $asst, $litm, msft, spx, $morf, $akro, $tsla, pypl, $qntm, pfe, $abt, $tsm, $mor, $cura, dtc, $alpn, $amd, $lgnd, market cap, qubt, $veon, $lyel, $fsm, $otly, avgo, sei, qqq, $hnsa, $repl, abus, mira, $nams, $ampx, oscr, neural, twitch, 3m, $1b, aur, hut, nasdaq, investment, $bslk, $li, $xrp, amzn, $mygn, aap, meta, $bzai, $meip, $gogo, $goos, $dk, $afmd, $nuvb, $crvs, aeg, crcl, smci, $bbai, $au, $pltr, xpof, $trmk, $nxliw, $gen, $lyv, $qvcc, $myn, $sono, aa, uber eats, newcastle united, $anab
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$AKRO $PCVX $ZLAB $PTCT $MRUS $RYTM $CYTK $ACAD $KRYS $CRSP $RNA $SWTX $RARE $ACLX $PTGX $KYMR $SRRK $CRNX $ALVO $HCM $IMVT $MIRM $IBRX $APGE $AMRX $XENE $APLS $LGND $ARWR $SRPT $VCYT $VCEL $BCRX $NAMS $KNSA $DNLI $TWST $AGIO $CGON $RXRX $NVCR $IDYA"
@linhnguyen64143 on X 2025-07-22 13:51:44 UTC XX followers, X engagements
"$DAVE $GMAB $NE $LRN $SIMO $TX $MRUS $ASTS $CRNX $MCHP $META $XENE $RVMD $GH $ORLA $PSLV $VRNA $WGS $TME $AAP $FROG $BZ $KSPI $TAL $IMVT $PAY $SBSW $EQNR $MIRM $HRMY $BBIO $AMD $RYTM $VAL $LION $CEF $URBN $CRDO $SYM $LTH $DRS $RBLX $ANET $NUVL"
@ZiMagicalTiger on X 2025-07-22 13:39:33 UTC X followers, XX engagements
"$APGE $VEON $RVMD $DNLI $AKRO $MRUS $NUVL $MCRB $VST $RDNT $RXRX $BA $MIRM $MHO $ACLX $PTGX $IBKR $ESLT $CRDO $MTH $SPR $IGT $SGHC"
@GoldGokuTrader on X 2025-07-22 13:34:35 UTC X followers, X engagements
"Qullamaggie Inspired Screener XX Stocks Least extended $RYTM $FORTY $KTOS $MP $CAR $SOFI $U $FUTU $ALGM $GHRS $OUST $MCRI $ASTS $NEXT $RKLB $CDTX $PARR $HOOD $LIF $EYE $PSIX $MRUS $FIVE $ONC $LEU $TME $PL $NVTS $GOGO $AAPG $KEP $SKE $SEDG $PLTR $BBAI $SMR $PRCH $RGTI $COMM $AU $ORLA $TWLO $SLNO $YALA $ARMN $QBTS $OKLO $GLIBK $ATRO $IHS Criteria: Relative Strength = XX (1W 1M 3M or 6M) Price = EMA10 = SMA20 = SMA50 = SMA100 = SMA200 ATR RS = XX (above average) Price-to-20-Day Range = XX% The market cap has been limited to $1B+ for liquidity purposes although Kristjan used a lower threshold"
@SteveDJacobs on X 2025-07-22 08:04:56 UTC 3453 followers, 3272 engagements